Article
Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents.
Antimicrobial agents and chemotherapy - 1 Aug 2003
Sanglard Dominique, Ischer Françoise, Parkinson Tania, Falconer Derek, Bille Jacques
Abstract excerpt
The role of sterol mutations in the resistance of Candida albicans to antifungal agents has not been thoroughly investigated. Previous work reported that clinical C. albicans strains resistant to both azole antifungals and amphotericin B were defective in ERG3, a gene encoding sterol Delta(5,6)-desaturase. It is also believed that a deletion of the lanosterol 14alpha-demethylase gene, ERG11, is possible only...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
